Targeting interleukin-1 in the treatment of rheumatoid arthritis
Arthritis Rheum
.
2002 Mar;46(3):574-8.
doi: 10.1002/art.10168.
Authors
Jean-Michel Dayer
,
Barry Bresnihan
PMID:
11920390
DOI:
10.1002/art.10168
No abstract available
Publication types
Comment
Editorial
Review
MeSH terms
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / physiopathology*
Humans
Interleukin-1 / physiology*
Tumor Necrosis Factor-alpha / physiology
Substances
Interleukin-1
Tumor Necrosis Factor-alpha